CHICAGO -- Availability of a bevacizumab biosimilar for ophthalmic use could eliminate a lower-cost treatment option for a ...

Cataracts, dry eyes, glaucoma, and other eye problems become more common with age. But these can be treated and even cured if ...

Ocuphire Pharma acquires Opus Genetics, expanding its IRD gene therapy pipeline. The renamed company, Opus Genetics, will trade under "IRD" by late024.

A panel of speakers demonstrated different ways technology and artificial intelligence (AI) could greatly expand access to ...

Diabetic retinopathy appears to be more common in young people than earlier thought, leaving more of them at risk for eye ...

Following its initial green light in wet age-related macular degeneration, Eylea has also picked up nods in diabetic macular ...

Ocuphire Pharma (OCUP) announced the all-stock acquisition of Opus Genetics. In connection with the merger, the combined company will be ...

The company will seek a strategic partner to continue development of APX3330, an oral small-molecule inhibitor of Ref-1 for ...

Acquisition creates a leading, clinical-stage company focused on the development of gene therapy treatments for rare inherited retinal ...

Researchers examined the differences in Diabetic Retinopathy Severity Scale scores using 7-modified or 4 wide-field color ...

Carrots are believed to support eye health because of their carotenoid content. Learn what’s true and best: raw, cooked, or ...

Light therapy could be a useful treatment for the most common form of age-related macular degeneration, a new study says.